Explore

Rapid Read Rapid Read
NIH Official Advocates for MAHA Strategy Amidst ADA Skepticism

NIH Official Advocates for MAHA Strategy Amidst ADA Skepticism

Richard Woychik, a senior adviser to the National Institutes of Health (NIH), endorsed the Make America Healthy Again (MAHA) strategy at the American Diabetes Association's (ADA) 2026 scientific sessions. The strategy, supported by Health and Human Services Secretary Robert F. Kennedy Jr., aims to integrate NIH-wide innovation to better understand and prevent diabetes. Woychik emphasized the need for an integrated approach to chronic diseases, highlighting diabetes as a key area. His speech followed the cancellation of NIH Director Jay Bhattacharya's appearance due to a scheduling conflict with President Trump. Woychik faced criticism from ADA's chief scientific officer, Rita Kalyani, regarding funding cuts and the erosion of research institutions. Despite skepticism, Woychik defended the strategy, citing the importance of understanding the root causes of chronic diseases.
Trendline Trendline
Eli Lilly and Novo Nordisk Compete at ADA 2026 Amid Rising Obesity Drug Market

Eli Lilly and Novo Nordisk Compete at ADA 2026 Amid Rising Obesity Drug Market

Eli Lilly and Novo Nordisk Compete at ADA 2026 Amid Rising Obesity Drug Market
Rapid Read Rapid Read
Jordan Klepper Engages Trump Supporter in Revealing Discussion on Military Conflicts

Jordan Klepper Engages Trump Supporter in Revealing Discussion on Military Conflicts

During a segment on 'The Daily Show,' host Jordan Klepper engaged a supporter of President Trump at an event celebrating America's 250th birthday in New Orleans. The conversation began with the supporter expressing optimism about the country's direction under President Trump. However, as Klepper probed further, the supporter acknowledged contradictions in his views, particularly regarding military conflicts. Klepper highlighted President Trump's campaign promise of 'no new wars,' prompting the supporter to concede that recent military actions contradicted this stance. The discussion also touched on the lack of transparency in the Jeffrey Epstein case, with the supporter agreeing that military conflicts might serve as a distraction from such issues. Ultimately, the supporter expressed uncertainty about voting for President Trump again, citing the potential use of military actions as a diversion as a significant concern.
Rapid Read Rapid Read
Trump Administration Proposes Rule Change to Increase Political Control Over Science Funding

Trump Administration Proposes Rule Change to Increase Political Control Over Science Funding

The Trump administration, led by Director Russell Vought of the White House Office of Management and Budget, has proposed a rule change that would allow political appointees to have more decision-making power over federal research grants. This proposal aims to replace the current merit-based peer review system with a process that critics argue could undermine scientific integrity and academic freedom. The rule would also ban research on diversity, equity, inclusion, and gender as grant conditions and prohibit international scientific collaborations. While supporters claim the change is intended to improve efficiency and address waste, fraud, and abuse, opponents fear it could jeopardize the integrity of scientific research.
Trendline Trendline
Insulet Corporation Showcases Omnipod Innovations at American Diabetes Association Conference

Insulet Corporation Showcases Omnipod Innovations at American Diabetes Association Conference

Insulet Corporation Showcases Omnipod Innovations at American Diabetes Association Conference
AP News AP News
Trump administration has separated dozens of children from their parents for a second time, AP finds

Trump administration has separated dozens of children from their parents for a second time, AP finds

An Associated Press investigation reveals that dozens of children who were separated under the first Trump administration have been re-separated, despite a judge's order to reunite them
Trendline Trendline
Cambrian Bio to Present ATX-304 Data at American Diabetes Association Sessions

Cambrian Bio to Present ATX-304 Data at American Diabetes Association Sessions

Cambrian Bio to Present ATX-304 Data at American Diabetes Association Sessions
Trendline Trendline
Cambrian Bio to Present ATX-304 Data at American Diabetes Association Meeting

Cambrian Bio to Present ATX-304 Data at American Diabetes Association Meeting

Cambrian Bio to Present ATX-304 Data at American Diabetes Association Meeting
Rapid Read Rapid Read
Insulet Showcases Omnipod Innovations at American Diabetes Association Sessions

Insulet Showcases Omnipod Innovations at American Diabetes Association Sessions

Insulet Corporation, a leader in tubeless insulin pump technology, is set to present new data and innovations at the American Diabetes Association's 86th Scientific Sessions in New Orleans. The company will highlight advancements in its Omnipod products, focusing on reducing user effort and improving clinical outcomes for diabetes management. Key presentations will include updates on the Omnipod 5 Automated Insulin Delivery System, featuring a new algorithm designed to enhance time in range and reduce disease burden. Insulet will also discuss findings from the STRIVE trial, which supports the regulatory submission of the next-generation Omnipod 6 system. The event will feature various sessions and presentations by leading diabetes experts, showcasing the company's commitment to patient-centered design and breakthrough algorithm performance.
Rapid Read Rapid Read
Cambrian Bio to Present Data on ATX-304 at American Diabetes Association Scientific Sessions

Cambrian Bio to Present Data on ATX-304 at American Diabetes Association Scientific Sessions

Cambrian Bio is set to present two posters on its lead therapeutic, ATX-304, at the American Diabetes Association's 86th Scientific Sessions in New Orleans. ATX-304 is a novel oral small molecule that activates AMPK and mitochondrial pathways, currently in clinical development for obesity and cardiometabolic diseases. The presentations will include data from a Phase 1b study in prediabetic obese participants and research on ATX-304's mechanism of action, highlighting its potential as a new treatment for metabolic decline.
Rapid Read Rapid Read
Concerns Over Press Freedom Under President Trump's Second Term

Concerns Over Press Freedom Under President Trump's Second Term

President Trump's second term has seen multiple attempts to restrict press freedom, raising concerns about the erosion of First Amendment rights. Over 16 months, there have been 15 notable incidents, including legal actions against major media outlets, access restrictions for journalists, and regulatory pressures. These actions have sparked debates about the balance between national security and the public's right to information. Historical tensions between the presidency and the press are being revisited, with Trump's administration taking a particularly aggressive stance against perceived media bias.
Rapid Read Rapid Read
Trump Administration Rewrites Higher Education Rules Amidst Controversy

Trump Administration Rewrites Higher Education Rules Amidst Controversy

The Trump administration is moving to rewrite federal rules governing higher education, following a year of investigations into universities. The new approach aims to embed demands previously pressed on individual schools into regulations affecting thousands of U.S. universities. The administration's focus includes diversity, equity, and inclusion policies, transgender athletes, and perceived anti-white discrimination. Proposed changes include overhauling the accreditation process to ensure 'intellectual diversity' and requiring federal grant recipients to certify they do not have DEI policies deemed unlawful by the administration. The shift comes after federal judges blocked cuts at Harvard and UCLA, and amidst a decline in new investigations.